Common Stock, Shares, Issued of REVIVA PHARMACEUTICALS HOLDINGS, INC. from 31 Aug 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
REVIVA PHARMACEUTICALS HOLDINGS, INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Aug 2018 to 30 Sep 2025.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 96,337,119, a 188% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 96,337,119 +62,895,920 +188% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 68,003,613 +38,186,319 +128% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 46,739,949 +18,821,389 +67% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 46,579,199 +18,660,639 +67% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 33,441,199 +12,790,933 +62% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 29,817,294 +7,167,028 +32% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 27,918,560 +7,466,439 +37% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 27,918,560 +7,471,189 +37% 31 Dec 2023 10-K 03 Apr 2025 2024 FY
Q3 2023 20,650,266 +207,395 +1% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 22,650,266 +7,516,980 +50% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 20,452,121 +5,318,835 +35% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 20,447,371 +6,014,085 +42% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 20,442,871 +7,053,885 +53% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 15,133,286 +1,744,300 +13% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 15,133,286 +5,901,549 +64% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 14,433,286 +5,201,549 +56% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 13,388,986 +10,582,858 +377% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 13,388,986 +10,646,051 +388% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 9,231,737 +6,527,150 +241% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 9,231,737 +6,608,475 +252% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 2,806,128 +195,638 +7.5% 31 Aug 2020 10-Q 14 Oct 2020 2020 Q2
Q2 2020 2,742,935 +137,749 +5.3% 31 May 2020 10-Q 07 Jul 2020 2020 Q1
Q1 2020 2,704,587 +102,122 +3.9% 29 Feb 2020 10-Q 14 Jan 2021 2020 Q3
Q4 2019 2,623,262 +22,727 +0.87% 30 Nov 2019 10-Q 10 Jan 2020 2019 Q3
Q3 2019 2,610,490 +14,208 +0.55% 31 Aug 2019 10-Q 08 Oct 2019 2019 Q2
Q2 2019 2,605,186 31 May 2019 10-Q 03 Jul 2019 2020 Q1
Q1 2019 2,602,465 28 Feb 2019 10-K 04 May 2020 2020 FY
Q4 2018 2,600,535 30 Nov 2018 10-Q 09 Jan 2019 2019 Q3
Q3 2018 2,596,282 31 Aug 2018 10-Q 11 Oct 2018 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.